Neuronopathic Gaucher Disease Neurological Severity Score

Evaluates neurological severity in Gaucher disease types 2 and 3 using horizontal saccadic eye movement velocity, cognitive function, myoclonic epilepsy burden, and response to substrate reduction therapy (eliglustat/miglustat)

Each component has a specific meaning:

• Horizontal saccadic eye movement velocity — The horizontal saccadic eye movement velocity recorded for the scenario being assessed.
• Cognitive function — The cognitive function recorded for the scenario being assessed.
• Myoclonic epilepsy burden — The myoclonic epilepsy burden recorded for the scenario being assessed.
• Response — The response recorded for the scenario being assessed.

Note: Interpret the gaucher neuro score result against the thresholds and context described above.

Enter the horizontal saccadic eye movement velocity, cognitive function, myoclonic epilepsy burden, response for the scenario you are assessing. Evaluates neurological severity in Gaucher disease types 2 and 3 using horizontal saccadic eye movement velocity, cognitive function, myoclonic epilepsy burden, and response to substrate reduction therapy (eliglustat/miglustat). Use the gaucher neuro score result to inform your calculation.